AzTrials
AzTrials

Traumatic Brain Injury (TBI) PatientsSPRINTNCT07794605

Sleep to Predict Recovery In Unconscious Patients With Acute Brain Injury

An observational study of Traumatic Brain Injury (TBI) Patients and Intracerebral Hemorrhage (ICH), run by Columbia University at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Severe brain injuries can leave people in states where they are unconscious or only partly aware, such as a coma. These conditions are common after injuries like head trauma or bleeding in the brain. One of the biggest challenges for doctors is knowing if - or when - a patient will wake up and regain awareness. Read more about this study

Who is it for?
Ages 18 years and older
How many people
230 participants
Where
2 sitesUnited States
Study dates
30 Oct 2026to 30 Oct 2031
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients admitted to the ICU with acute neurological injury with Disorders of Consciousness (traumatic brain injury, and intracerebral hemorrhage) who demonstrate impaired consciousness and are unable to follow commands based on standardized clinical assessments (e.g., CRS-R).

Who may be able to join

  • Adults with non-penetrating traumatic brain injury (TBI) or with primary intracerebral hemorrhage (ICH) (i.e. from hypertension or anticoagulants) who remain behaviorally unresponsive to verbal commands (i.e., comatose vegetative state, or minimally conscious state minus [MCS-minus, defined as unresponsive with preserved visual fixation/pursuit or localization to noxious stimuli]) by day 2 after injury

Who cannot join

  • Evidence of consciousness within 2 days of injury
  • Uncontrolled seizures
  • pre-existing disorders of consciousness
  • deafness

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Jan Claassen, MD contact

212-305-7236

jc1439@cumc.columbia.edu

Angela Velazquez, MD contact

212-305-6071

agv2113@cumc.columbia.edu

United States2 sites, 2 recruiting
  • University of Miami and Jackson Health System (UM/JHS)

    Miami, Florida, 33136

    Ayham Alkhachroum, MD, 305-243-6175, axa2610@med.miami.edu

    Ayham Alkhachroum, MD

    Not yet recruiting
  • Columbia University Medical Center

    New York, New York, 10032

    Jan Claassen, MD, 212-305-7236, jc1439@cumc.columbia.edu

    Jan Claassen, MD

    Recruiting

Other trials in United States

About this study

Severe brain injuries can leave people in states where they are unconscious or only partly aware, such as a coma. These conditions are common after injuries like head trauma or bleeding in the brain. One of the biggest challenges for doctors is knowing if - or when - a patient will wake up and regain awareness.

This research study is being done to determine if patterns in brain activity during sleep (measured by EEG) can help doctors better predict how quickly someone will wake up and recover after a serious brain injury, as well as how well they might do in the long term. It also aims to develop new ways of using EEG to track how the brain's networks heal and reconnect over time.

Read the detailed description

Disorders of consciousness (DoC), including coma and other states of impaired awareness, are common following severe acute brain injury, particularly traumatic brain injury (TBI) and intracerebral hemorrhage (ICH). Predicting whether and when these patients will recover consciousness remains one of the greatest challenges in neurocritical care. Current prognostic tools are limited, and inaccurate predictions may influence critical decisions regarding ongoing treatment and goals of care.

Previous work has demonstrated that cognitive motor dissociation (CMD) - brain activation detected by EEG in response to motor commands despite the absence of observable behavioral responses - is associated with long-term recovery. However, CMD testing has important limitations, including false-negative results in patients with aphasia, hearing impairment, language barriers, or fluctuating arousal.

Sleep architecture is profoundly disrupted after severe brain injury. Emerging evidence suggests that the presence of well-formed sleep spindles (WFSS) on EEG reflects preserved thalamocortical network integrity and is associated with recovery of consciousness and improved neurological outcomes. Sleep spindle detection offers a potentially scalable, inexpensive, and language-independent biomarker that can be obtained passively during routine EEG monitoring.

This study seeks to determine whether EEG sleep features, particularly WFSS, can improve prediction of early recovery of consciousness and long-term neurological outcomes while also developing novel EEG-based measures of functional network recovery.

Keywords
cognitive motor dissociation (CMD), Disorders of Consciousness
Medical subject headings
Brain Injuries, Traumatic, Cerebral Hemorrhage, Consciousness Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07794605
Study groupRoleWhat they receive
Intracerebral Hemorrhage and Traumatic Brain InjuryAdult patients with acute neurological injury with Disorders of Consciousness (traumatic brain injury, and intracerebral hemorrhage).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. P-value for prediction of the detection of cognitive motor dissociation (CMD)

    P-value for separating move vs non-move instructions on power spectral density data using a support vector machine learning algorithm.

    Measured: Day 9

  2. Prediction of recovery of consciousness by day 28 after brain injury

    Recovery of consciousness will be determined using the Coma Recovery Scale-Revised Scale (CRS-R) indexing consciousness as either minimally conscious state-plus (MCS-plus: the presence of signs of conscious awareness that include responses to commands or intelligible verbal output) or emergence from a minimally conscious state (EMCS: the return of the ability to use common objects in a functional manner or correctly respond to basic yes-or-no questions about situational orientation). Both would qualify as recovery of consciousness. The CRS-R full score ranges from 0 to 23, with higher scores representing higher levels of consciousness.

    Measured: Day 28

  3. Sleep as a prognosticator of long-term independence and disability after traumatic brain injury (TBI)

    This outcome will be assessed using the Glasgow Outcome Scale-Extended (GOS-E) Scale, which is an 8-level standardized clinical scale used to measure functional recovery and independence after a brain injury. Higher GOS-E scores indicate a better recovery, higher functional independence, and a greater return to normal daily activities. GOS-E score of ≥4 by 12-month post injury will serve as the primary measure to define independence indicating that the participant can be left alone at home for at least 8 hours in a day.

    Measured: 12 months post injury

  4. Sleep as a prognosticator of long-term disability after intracerebral hemorrhage (ICH)

    This outcome will be assessed using the Modified Rankin Scale (mRS). The full score ranges from 0 to 6, measuring the degree of disability or dependence in daily activities. Higher scores mean greater disability and dependence, whereas lower scores mean better recovery and independence. Recovery from disability will be set at a score of 3 or below by 12 months post injury, indicating no more than moderate disability, where a person requires some help with daily activities but is still able to walk without assistance.

    Measured: 12 months post injury

Secondary outcomes (13)
  1. Recovery of consciousness (CRS-R score ≥ 8)

    Number of participants who have a Coma Recovery Scale-Revised (CRS-R) score of 8 or above.

    Measured: Day 28 after brain injury

  2. Recovery of consciousness (CRS-R score = 10)

    Number of participants who have a Coma Recovery Scale-Revised (CRS-R) score of 10.

    Measured: Day 28 after brain injury

  3. Recovery of consciousness

    Presence of subtle clinical signs of consciousness

    Measured: Day 28 after brain injury

  4. Recovery of consciousness using the CRSR-FAST

    Coma Recovery Scale-Revised For Accelerated Standardized Testing (CRSR-FAST) score does not use a numerical scoring range like the full-length test; instead, it results in a binary rating of "conscious" or "not conscious." If at least one of the five core behaviors are present, the participant is considered conscious.

    Measured: Day 28 after brain injury

  5. Recovery of consciousness (mean CRS-R score)

    Average CRS-R scores following equal interval transformation using the partial credit Rash model.

    Measured: Day 28 after brain injury

  6. Delirium as detected by the CAM-ICU score

    The CAM-ICU (Confusion Assessment Method for the Intensive Care Unit) is a bedside tool used to screen for delirium in critically ill or mechanically ventilated patients. Instead of a numeric point scale, it yields a positive or negative result for delirium based on four specific clinical features.

    Measured: Day 28 after brain injury

  7. Recovery of independence for all patients

    Number of participants who have a Glasgow Outcome Scale-Extended score of ≥4

    Measured: 12 month post injury

  8. Long term disability

    utility weighted transformation of modified Rankin Scale score

    Measured: 12 months after injury

  9. Quality of life as per the Neuro-QOL scale

    Quality of Life in Neurological Disorders (Neuro-QOL) to quantify quality of life as a patient-reported outcome measure. Neuro-QOL uses a standardized T-score metric where the mean of a reference population is set at 50 and the standard deviation is 10. Scores above or below 50 represent better or worse health-related quality of life than the reference group, depending on the specific symptom or functional domain.

    Measured: 12 months post injury

  10. Disability

    Disability will be evaluated using the Disability Rating Scale (DRS), which ranges from 0 to 29, where higher scores indicate a greater level of impairment.

    Measured: 12 months post injury

  11. GOS-E sliding dichotomy for TBI participants

    Evaluating recovery after traumatic brain injury (TBI) using a sliding dichotomy with the IMPACT Score tailors the definition of a "favorable" functional outcome to each participant's unique baseline prognosis. Instead of applying a single fixed cutoff (e.g., GOS-E ≥ 4 for everyone), this method sets a customized recovery threshold for each participant based on their predicted baseline risk profile. A participant recovering better than their individual baseline prediction is classified as a "favorable" outcome

    Measured: 12 months post injury

  12. GOS-E sliding dichotomy for ICH participants

    Evaluating recovery after intracerebral hemorrhage (ICH) using a sliding dichotomy with the FUNC Score tailors the definition of a "favorable" functional outcome to each participant's unique baseline prognosis. Instead of applying a single fixed cutoff, this method sets a customized recovery threshold for each participant based on their predicted baseline risk profile. A participant recovering better than their individual baseline prediction is classified as a "favorable" outcome.

    Measured: 12 months

  13. Return to work

    Participants will be assessed if they were able to return to work as measured by the GOS-E with a score of 6 or above, indicating they are able to return to work even with special arrangements.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2026
  2. Study start30 Oct 2026
  3. Primary completion30 Oct 2030 (estimated)
  4. Study completion30 Oct 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
230 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07794605
Sponsor's protocol ID
ACYY2746
Other IDs
1R01NS145481-01A1
Acronym
SPRINT
Status last verified
Oct 2026
First submitted
26 Aug 2026
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Traumatic Brain Injury (TBI) Patients and Intracerebral Hemorrhage (ICH), run by Columbia University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jan Claassen, MD (212-305-7236, jc1439@cumc.columbia.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

P-value for prediction of the detection of cognitive motor dissociation (CMD) (time frame: Day 9). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in